Here is what the page “At Shanghai's 'Science City', China's Biotech Boom Goes Global with Deal-Making Pitch” contains. In Shanghai's Zhangjiang 'Science City', a small but ambitious conference is showcasing China's rapidly growing biotech sector to the world, drawing comparisons to a major U.S. The event highlights how Chinese biotechs, such as those based in the Zhangjiang Hi-Tech Park, are increasingly seeking international partnerships and investment. Key players include local startups and established firms that are advancing novel therapies, with the conference serving as a platform for pitching to global pharma and investors.
The growth mirrors China's broader push to become a leader in innovative drugs, moving beyond generics. Why it matters: as Chinese biotechs mature, they are becoming significant players in global drug development, offering potential collaborations and competition for Western companies. The conference's intimate setting fosters networking, with attendees noting the quality of science and the eagerness for cross-border deals. This listing links straight to the original page, where the content is available in full.